On June 12, 2025, Neurogene Inc. held its Annual Meeting, where stockholders approved amendments to the 2023 Equity Incentive and Employee Stock Purchase Plans, impacting the automatic share reserve calculations. The meeting recorded approximately 11.48 million shares present, constituting about 80.50% of voting power.